Stemergie develops treatments and diagnostics for cancers by targeting cancer-initiating cells (CIC), the roots of cancer.

Stemergie's CIC based technology platform allows the identification, validation and development of trea...
See More tments against brain CIC. With its proprietary methodology Stemergie is able to identify, isolate and enrich CIC independently of markers. Stemergie plans to translate this technology to further types of CIC, in order to treat and diagnose melanoma as well as further oncology indications.